BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li H, Zou Y, Xia Z, Gao F, Feng J, Yang C. Effects of topiramate on weight and metabolism in children with epilepsy. Acta Paediatrica 2009;98:1521-5. [DOI: 10.1111/j.1651-2227.2009.01349.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Grondhuis SN, Aman MG. Overweight and obesity in youth with developmental disabilities: a call to action: Overweight and obesity. J Intellect Disabil Res 2014;58:787-99. [DOI: 10.1111/jir.12090] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 4.2] [Reference Citation Analysis]
2 Ozcelik AA, Serdaroglu A, Bideci A, Arhan E, Soysal Ş, Demir E, Gücüyener K. The Effect of Topiramate on Body Weight and Ghrelin, Leptin, and Neuropeptide-Y Levels of Prepubertal Children With Epilepsy. Pediatric Neurology 2014;51:220-4. [DOI: 10.1016/j.pediatrneurol.2014.05.001] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
3 Toscano ECDB, Lessa JMK, Gonçalves AP, Rocha NP, Giannetti AV, de Oliveira GN, Rachid MA, Vieira ÉLM, Teixeira AL. Circulating levels of adipokines are altered in patients with temporal lobe epilepsy. Epilepsy & Behavior 2019;90:137-41. [DOI: 10.1016/j.yebeh.2018.11.023] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
4 Pal R, Singh K, Khan SA, Chawla P, Kumar B, Akhtar MJ. Reactive metabolites of the anticonvulsant drugs and approaches to minimize the adverse drug reaction. Eur J Med Chem 2021;226:113890. [PMID: 34628237 DOI: 10.1016/j.ejmech.2021.113890] [Reference Citation Analysis]
5 Verrotti A, Scaparrotta A, Agostinelli S, Di Pillo S, Chiarelli F, Grosso S. Topiramate-induced weight loss: A review. Epilepsy Research 2011;95:189-99. [DOI: 10.1016/j.eplepsyres.2011.05.014] [Cited by in Crossref: 61] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
6 Cansu A. Antiepileptic drugs and hormones in children. Epilepsy Research 2010;89:89-95. [DOI: 10.1016/j.eplepsyres.2009.09.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
7 Verrotti A, Parisi P, Agostinelli S, Loiacono G, Marra F, Coppola G, Pisani LR, Gorgone G, Striano P, Pisani F, Belcastro V. Weight Regain after Discontinuation of Topiramate Treatment in Patients with Migraine: a Prospective Observational Study. CNS Drugs 2015;29:163-9. [DOI: 10.1007/s40263-015-0229-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
8 Manzini S, Busnelli M, Parolini C, Minoli L, Ossoli A, Brambilla E, Simonelli S, Lekka E, Persidis A, Scanziani E, Chiesa G. Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids. Pharmacol Res 2019;141:189-200. [PMID: 30593851 DOI: 10.1016/j.phrs.2018.12.022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
9 Sleddering MA, Snel M, Streefland TC, Pijl H, Jazet IM. Short-term topiramate treatment does not improve insulin sensitivity or secretion in obese insulin-resistant women. Eur J Endocrinol 2012;167:839-45. [PMID: 22983924 DOI: 10.1530/EJE-12-0500] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
10 White R. Drugs and nutrition: how side effects can influence nutritional intake. Proc Nutr Soc 2010;69:558-64. [DOI: 10.1017/s0029665110001989] [Cited by in Crossref: 16] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
11 Vidigal CB, Moura KF, Costa TJ, Borges LI, Figaro PMM, Pinto IC, de Andrade FG, Gerardin DCC, Casagrande R, Tostes RC, Franco MDC, Ceravolo GS. Topiramate treatment in Wistar rats during childhood induces sex-specific vascular dysfunction in adulthood. Life Sci 2022;288:120189. [PMID: 34863798 DOI: 10.1016/j.lfs.2021.120189] [Reference Citation Analysis]
12 Yaman M, Ucok K, Demirbas H, Genc A, Oruc S, Karabacak H, Koyuncu G. Effects of topiramate use on body composition and resting metabolic rate in migraine patients. Neurol Sci 2013;34:225-9. [DOI: 10.1007/s10072-012-0977-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
13 Moavero R, Santarone ME, Galasso C, Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain and Development 2017;39:464-9. [DOI: 10.1016/j.braindev.2017.01.006] [Cited by in Crossref: 57] [Cited by in F6Publishing: 45] [Article Influence: 11.4] [Reference Citation Analysis]
14 Okuyaz C, Kursel O, Komur M, Tamer L. Evaluation of appetite-stimulating hormones in prepubertal children with epilepsy during topiramate treatment. Pediatr Neurol 2012;47:423-6. [PMID: 23127262 DOI: 10.1016/j.pediatrneurol.2012.08.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
15 Catoira N, Nagel M, Di Girolamo G, Gonzalez CD. Pharmacological treatment of obesity in children and adolescents: current status and perspectives. Expert Opinion on Pharmacotherapy 2010;11:2973-83. [DOI: 10.1517/14656566.2010.512005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
16 Özcan Ö, Arslan M, Güngör S, Yüksel T, Selimoğlu MA. Plasma Leptin, Adiponectin, Neuropeptide Y Levels in Drug Naive Children With ADHD. J Atten Disord 2018;22:896-900. [DOI: 10.1177/1087054715587095] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
17 Sonmez FM, Zaman D, Aksoy A, Deger O, Aliyazicioglu R, Karaguzel G, Fazlioglu K. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy. Seizure 2013;22:856-61. [PMID: 23937963 DOI: 10.1016/j.seizure.2013.07.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
18 Shapiro M, Reid A, Olsen B, Taasan M, McNamara J, Nguyen M. Topiramate, zonisamide and weight loss in children and adolescents prescribed psychiatric medications: A medical record review. Int J Psychiatry Med 2016;51:56-68. [PMID: 26681236 DOI: 10.1177/0091217415621266] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
19 Shlobin NA, Sander JW. Drivers for the comorbidity of type 2 diabetes mellitus and epilepsy: A scoping review. Epilepsy Behav 2020;106:107043. [PMID: 32217418 DOI: 10.1016/j.yebeh.2020.107043] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]